Stock Market & Financial Investment News

News Breaks January 28, 2013 06:07 EDT IMGN ImmunoGen downgraded to Perform from Outperform at Oppenheimer Oppenheimer downgraded ImmunoGen citing valuation and keeps a $14 price target for shares. The firm believes success of T-DM1 is now fully priced into shares. News For IMGN From The Last 14 Days Check below for free stories on IMGN the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. May 21, 2013 07:44 EDT IMGN Sachs Associates to host a forum Subscribe for More Information May 16, 2013 07:29 EDT IMGN Leerink to host a bus tour Boston Biopharma Bus Tour travels throughout Boston on May 16-17. May 10, 2013 07:24 EDT IMGN Credit Suisse to host a conference Subscribe for More Information Sign up for a free trial to see the rest of the stories you've been missing.